Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(128 sites)
Australia
Queensland Children's Hospital, Brisbane Chris O'brien Lifehouse, Camperdown Monash Children's Hospital, Clayton Peter Maccallum Cancer Centre, Melbourne Royal Childrens Hospital Melbourne, Melbourne